source
- Roche's daily incretin injection shows promise in Phase 2 trial for type 1 diabetesRoche reported that its experimental daily incretin injection achieved positive results in a Phase 2 study involving patients with type 1 diabetes. The study, the first mid-stage trial of a GLP-1…
- Innovent Biologics reports Phase 3 success for stomach cancer ADC, now under priority review in ChinaInnovent Biologics announced that its antibody‑drug conjugate (ADC) candidate has met the primary endpoint in a Phase 3 trial for advanced stomach cancer. The positive outcome has placed the produ…